To The Moon

Dec 13 - Pfizer on Wednesday forecast 2024 revenue that was below Wall Street expectations, and increased its target for cost cuts by $500 million. The U.S. drugmaker expects its annual revenue to be in the range of $58.5 billion to $61.5 billion compared with analysts' average estimate of $63.07 billion.

Justin Sullivan/Getty Images News Elevator Pitch My Buy investment rating for Nvidia Corporation shares stays intact. In my prior update for NVDA, written on April 6, 2023, I noted my expectations of "Nvidia's shares rising above $300" taking into account the fact that it "is well-positioned to leverage on generative AI growth opportunities." Nvidia Corporation's stock price has since risen by +46% to close at $394.82 as of June 12, 2023. I determine that there is a very good chance of NVDA's shares going up further to $500 with the current article, which supports my Buy rating for the stock. Nvidia Corporation has yet to fully exploit AI-related growth opportunities, and the implied price/earnings to growth or PEG multiple for NVDA at the $500 price level is still pretty reasonable. Is Nvidia Stock Expected To Go Up Further?

Semiconductor stocks tumbled in morning trading; TSMC shares slumping over 5%.

The high-profile biotech gets slammed with a few pieces of bad news.

The company is still waiting for the FDA to give Emergency Use Authorization for its COVID-19 vaccine.

Stock has risen 11 straight days, adding roughly $400 billionSeen earnings estimates upgraded; defie

After Amazon, Alphabet, and Tesla, these industry leaders could divvy up their high-priced shares next.

Amazon.com, Inc. (NASDAQ: AMZN) shares were trading more than 7% higher after-hours following the co